PR
Protect Pharmaceutical Corporation
PRTT · OTC
$0.22 -12.00% (-$0.03)
1M -40.54%
Market Cap $25.9M
P/E Ratio 0.52x
Div. Yield -
ROE 14.71%
Bulios Fair Price
$0.3
36.4% upside
Current Price
$0.22
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PRTT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/E 0.52x
P/B 0.07x
EV/EBITDA 0.21x
Growth
100 /100
Growing EPS growth 39.63%
Book val. growth 17.39%
Rev. growth 18.84%
Profitability
76 /100
Strong Gross margin 59.61%
FCF margin 2.39%
Net margin 43.90%
Quality
67 /100
Excellent ROIC 12.98%
Asset turnover 0.27x
ROE 14.71%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -0.31x
Current ratio 3.37x
Stability
31 /100
Unstable Beta 2.21x
Profitable years 4
Rev. volatility 38.24%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRTT
Online
Sector
Industrials
Industry
Airlines, Airports & Air Services
CEO
Boris Stepanov
Employees
600
Headquarters
Las Vegas